Lipid Emulsion in Cardiac Valve Replacement Surgery

Status Not yet recruiting

Clinical Trial Summary

Myocardial protection has become an essential adjunctive measure in cardiac surgery to bail the myocardium out of ischemia/reperfusion-induced damage during the operation. Experimental studies have shown that lipid emulsion infusion just before reperfusion (i.e., intralipid postconditioning (ILPC)) could reduce myocardial infarct sizes, improve cardiac function, and reduce myocardial I/R injuries, despite the interesting experimental findings, the potential clinical usage of lipid emulsion in preventing myocardial I/R injury needs to be further investigated.

Clinical Trial Description

The study of myocardial protection has improved aiming to prevent intraoperative myocardial injury, which can lead to ventricular dysfunction, arrhythmias, low cardiac output and other complications, often irreversible ones. Nowadays there are numerous methods of myocardial protection during cardiac surgery, But still there is no best myocardial protection technique. Despite improved myocardial protection strategies, cardioplegic arrest and ischemia still result in ischemic reperfusion injury during cardiac surgery. Many drugs have proved a pharmacological postconditioning effect on the heart at the onset of reflow and had been shown to limit infarction size and decrease the ischemic/reperfusion injury ,Postconditioning (POC) has been reported to promote left ventricular functional recovery after global ischemia with cardioplegic arrest on cardiopulmonary bypass in a large animal model Smoflipid is a sterile safe lipid emulsion comprised of soybean oil (30%), medium chain triglycerides (30%) olive oil (25%) & fish oil (15%) that has been associated with decreased oxidative injury, improved liver function and increased antioxidant activity. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04951791
Study type	Interventional
Source	Assiut University
Contact	sara abdallah
Phone	01009556520
Email	sara92abdallah@gmail.com
Status	Not yet recruiting
Phase	N/A
Start date	August 2021
Completion date	October 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02134314` - C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI	Phase 1/Phase 2
Recruiting	`NCT01476969` - Effect of Remote Ischemic Perconditioning on Acute Kidney Injury in Adult Valve Replace	N/A
Completed	`NCT03050489` - Assessment of Myocardial Ischemic-Reperfusion Injury During Off- and On- Pump CABG
Recruiting	`NCT02940600` - Efficacy Evaluation of Normothermic Perfusion Machine Preservation in Liver Transplant Using Very Old Donors	N/A
Recruiting	`NCT02729155` - Single-cycle Remote Ischemic Preconditioning and Postconditioning for Prevention of Contrast-Induced Nephropathy	N/A
Recruiting	`NCT02649309` - Single-cycle Remote Ischemic Preconditioning and Postconditioning (SCRIP) Trial	N/A
Completed	`NCT02290080` - Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers	Phase 3
Not yet recruiting	`NCT04068116` - Impact of Ischemic Post-conditioning	N/A
Terminated	`NCT01726465` - Methylprednisolone N Acetylcysteine in Hepatic Resections	Phase 2
Completed	`NCT03535623` - RIPC During Free Flap With Preoperative Radiotherapy	N/A
Completed	`NCT02581618` - Remote Ischemic Preconditioning in Elective Percutaneous Interventions	N/A
Recruiting	`NCT04000334` - Early Transcranial Doppler Goal Directed Therapy After Cardiac Arrest: a Pilot Study	N/A
Completed	`NCT01887171` - Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus	N/A
Recruiting	`NCT05148715` - Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)	Phase 2
Recruiting	`NCT05661227` - Mechanism of Cardiac and Cerebral Function Injury Caused by Intraoperative Limb Ischemia-reperfusion	N/A
Completed	`NCT04257240` - Recurrence of Liver Malignancy After Ischemia/Reperfusion Injury
Active, not recruiting	`NCT05708053` - Cardio-protective Effect of Metformin in Patients Undergoing PCI	Phase 3
Completed	`NCT05194306` - PERTRIAL - Perla® Preservation Solution	N/A
Recruiting	`NCT05179434` - A Study of Retrograde Reperfusion of Renal Graft to Reduce Ischemic-reperfusion Injury	N/A
Completed	`NCT01666587` - Ischemia Reperfusion: Prostaglandins and Antioxidants	N/A